We are studying the effects of hyperthermic intraperitoneal chemotherapy (HIPEC) combined with standard care for ovarian cancer patients. This trial aims to see if HIPEC improves survival and quality of life compared to standard treatments alone.
Health conditions and diseases that the clinical trial is designed to study and treat.
Ovarian and Fallopian Tube Cancer includes cancers that originate in the ovaries or fallopian tubes, often leading to symptoms such as abdominal swelling, pelvic pain, and changes in bowel habits. These cancers can be serious and require prompt medical attention.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.